We are live on ! Find out more
OSTX icon

OS Therapies

7 hedge funds and large institutions have $601K invested in OS Therapies in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

390% more capital inflows, than outflows

Capital inflows: $648K | Capital outflows: $132K

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

17% more funds holding

Funds holding: 6 → 7 (+1)

1.11% more ownership

Funds ownership: 0.69% → 1.79% (+1.1%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OSTX Hedge Fund Activity: Q1 2025 in Review

7 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in OS Therapies (OSTX) for Q1 2025, worth a combined $601K — down 3.7% from $624K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new OSTX positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was CM Management, adding an estimated $446K. The largest seller was Millennium Management, exiting entirely with an estimated $128K sold.

  • 7 institutional investors held OS Therapies (OSTX) as of Q1 2025, up from 6 in Q4 2024.
  • Funds reported $601K of OS Therapies stock for Q1 2025, down 3.7% quarter-over-quarter.
  • 2 funds opened new OS Therapies positions in Q1 2025 and 1 closed out, a net change of +1 holder.
  • The largest OS Therapies buyer in Q1 2025 was CM Management, an estimated $446K added.
  • The largest OS Therapies seller in Q1 2025 was Millennium Management, an estimated $128K sold.

Based on aggregated 13F filings for Q1 2025.